STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN OLIGOMETASTATIC AND OLIGOPROGRESSIVE GYNECOLOGIC CANCERS: CLINICAL OUTCOMES OF A SINGLE INSTITUTION ANALYSIS

被引：0
|
作者：
Donovan, Elysia K. [1 ]
Cheung, Patrick [1 ]
Davidson, Melanie [1 ]
Gien, Lilian T. [1 ]
Leung, Eric [1 ]
Erler, Darby [1 ]
Saghal, Arjun [1 ]
Chung, Hans [1 ]
Poon, Ian [1 ]
Taggar, Amandeep [1 ]
Barnes, Elizabeth [1 ]
Jerzak, Katarzyna [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 150卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
198
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic and Oligoprogressive Gynecologic Cancers: Clinical Outcomes of a Single Institution Analysis
    Donovan, E.
    Cheung, P.
    Erler, D.
    Davidson, M. T. M.
    Sahgal, A.
    Chung, H. T.
    Poon, I.
    Taggar, A.
    Barnes, E.
    Jerzak, K.
    Gien, L. T.
    Leung, E. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E179 - E180
  • [2] Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic Gynecologic Malignancies: A Single Institution Experience
    Cuttino, L. W.
    Evans, J. E.
    Snyder, W. J.
    Ford, T. C.
    Egloff, S. Arnold
    Boardman, C. H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E266 - E266
  • [3] Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological Malignancies
    Mesko, Shane
    Sandler, Kiri
    Cohen, Joshua
    Konecny, Gottfried
    Steinberg, Michael
    Kamrava, Mitchell
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (02) : 403 - 408
  • [4] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [5] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [6] Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience
    Armstrong, S.
    Makris, A.
    Belessiotis-Richards, K.
    Abdul-Latif, M.
    Ostler, P.
    Shah, N.
    Miles, D.
    Tsang, Y. M.
    [J]. CLINICAL ONCOLOGY, 2024, 36 (06) : 362 - 369
  • [7] A REVIEW OF CURRENT STEREOTACTIC ABLATIVE RADIOTHERAPY CLINICAL TRIALS FOR OLIGOMETASTATIC CANCERS
    Arifin, Andrew
    Al-Shafa, Faiez
    Rodrigues, George B.
    Palma, David A.
    Louie, Alexander V.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S44 - S44
  • [8] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [9] Stereotactic Ablative Radiotherapy (SABR) for Prostate Cancer - an Analysis of 500 Consecutive Patients Treated at a Single Institution
    Miszczyk, L.
    Namysl-Kaletka, A. J.
    Napieralska, A.
    Kraszkiewicz, M.
    Miszczyk, M.
    Wozniak, G.
    Stapor-Fudzinska, M.
    Glowacki, G.
    Tukiendorf, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E295 - E295
  • [10] Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial
    Senan, S.
    Olson, R.
    Harrow, S.
    Gaede, S.
    Louie, A.
    Haasbeek, C.
    Mulroy, L.
    Lock, M.
    Rodrigues, G.
    Yaremko, B.
    Schellenberg, D.
    Ahmad, B.
    Griffioen, G.
    Senthi, S.
    Liu, M.
    Moore, K.
    Currie, S.
    Bauman, G.
    Warner, A.
    Palma, D.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345